Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Nine out of 10 members of the House of Representatives and all but three of the US’s 100 senators have taken campaign contributions from pharmaceutical companies seeking to affect legislation on everything from the cost of drugs to how new medicines are approved.
- Simplified Text
-
90% of House members and 97% of Senators took campaign contributions from pharmaceutical companies
- Confidence Score
- 0.900
- Claim Maker
- Chris McGreal
- Context Type
- News Article
- Context Details
-
{ "industry": "Pharmaceutical", "location": "US Congress", "influence": "Campaign contributions", "percentage_house": "90%", "percentage_senate": "97%" } - Subject Tags
- UUID
- 9fdb30b3-62f8-4aea-8c3c-ad43a787ee3a
- Vector Index
- ✗ No vector
- Created
- September 12, 2025 at 12:40 AM (10 hours ago)
- Last Updated
- September 12, 2025 at 12:40 AM (10 hours ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
23
claims
🔥
10 hours ago
https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis
Pharmaceutical industry lobbying and campaign contributions heavily influence US politics, hindering efforts to curb the opioid crisis. This influence is seen in legislation, impacting drug pricing and the DEA's ability to regulate opioid distribution.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.